ACAD
Acadia Pharmaceuticals Stock Analysis
AI Rating
- Quality8/10
- Growth↑ 9/10
- Value↓ 4/10
ACAD Growth
- Revenue Y/Y↑ 7.54%
- EPS Y/Y↑ 61.59%
- FCF Y/Y↓ -23.48%
ACAD Profitability
- Gross margin ↑ 91.50%
- EPS margin↑ 34.30%
- ROIC 5Y↓ 20.37%
ACAD Risk
- Debt / Equity↓ 0.0
- Debt / FCF↓ 0.0
- Interest coverage↓ NA
Acadia Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.